William A. Curran
Lawyers
Filters
Suja Life sale to Paine Schwartz Partners
We advised Suja Life on the sale
Novo Nordisk acquisition of Neotope Neuroscience
We advised Novo Nordisk on the acquisition
Novo Holdings investment in Availity
We advised Availity on the investment
Elliott Opportunity II $609.5 million IPO
We advised Elliott Opportunity II Corp., a SPAC, on its IPO and NYSE listing
XP $750 million notes offering
We advised XP on its Rule 144A / Regulation S offering of senior unsecured notes
StoneCo $500 million notes offering
We advised StoneCo on its Rule 144A / Regulation S offering of senior notes
Lydall $1.3 billion acquisition by Unifrax
We are advising Lydall on the transaction
Raven Industries $2.1 billion acquisition by CNH Industrial
We are advising Raven Industries on the transaction
Mitsubishi HC Capital acquisition of CAI International
We are advising Mitsubishi HC Capital on the acquisition
Nubank $750 million Series G-1 financing
We advised Nubank on its Series G-1 financing